Label | Development set | Test sets | |||
Training set N=46 501 | Validation set N=10 237 | Intern test set N=3 579 | External test set A N=1 245 | External test set B N=3 352 | |
Normal fundus | 19146 (41.2) | 4315 (9.3) | 1053 (29.4) | 441 (12.3) | 1804 (50.4) |
Retinal vein occlusion | 3528 (7.6) | 967 (2.1) | 531 (14.8) | 54 (1.5) | 123 (3.4) |
Referable diabetic retinopathy | 2701 (5.8) | 642 (1.4) | 285 (8.0) | 292 (8.2) | 388 (10.8) |
Pathological myopic retinal degeneration | 8243 (17.7) | 989 (2.1) | 192 (5.4) | 84 (2.3) | 113 (3.2) |
Retinitis pigmentosa | 587 (1.3) | 137 (0.3) | 130 (3.6) | 62 (1.7) | 38 (1.1) |
Retinal detachment | 315 (0.7) | 88 (0.2) | 110 (3.1) | 5 (0.1) | 14 (0.4) |
Epiretinal membrane | 2403 (5.2) | 544 (1.2) | 268 (7.5) | 36 (1.0) | 165 (4.6) |
Dry age-related macular degeneration | 2669 (5.7) | 808 (1.7) | 267 (7.5) | 86 (2.4) | 404 (11.3) |
Wet age-related macular degeneration | 1564 (3.4) | 433 (0.9) | 146 (4.1) | 67 (1.9) | 75 (2.1) |
Macular hole | 266 (0.6) | 59 (0.1) | 137 (3.8) | 1 (0.0) | 14 (0.4) |
Possible glaucomatous optic neuropathy | 3648 (7.8) | 544 (1.2) | 270 (7.5) | 79 (2.2) | 227 (6.3) |
Papilledema | 2882 (6.2) | 682 (1.5) | 228 (6.4) | 78 (2.2) | 82 (2.3) |
Optic nerve atrophy | 1459 (3.1) | 462 (1.0) | 202 (5.6) | 23 (0.6) | 150 (4.2) |
The results are presented with: number (%).